Is the paradigm shifting?

Bone

Volumn 33, Issue 4, 2003, Pages 457-465

  Heaney, Robert P ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

BMD; Bone mass; Bone remodeling; Paradigm; Remodeling biomarkers

Indexed keywords

BONE FRAGILITY; BONE MASS; BONE MINERAL; BONE REMODELING; BONE STRENGTH; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FRACTURE; OSTEOPOROSIS; REVIEW;

EID: 0141527583     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00236-9     Document Type: Article

References (44)

1. Abbott S., Trinkaus E., Burr D.B. Dynamic bone remodeling in later Pleistocene fossil hominids. Am J Phys Anthropol. 99:1996;585-601.
2. Aloia J.F., Mikhail M., Pagan C.D., Arunacha-Lam A., Yeh J.K., Flaster E. Biochemical and hormonal variables in black and white women matched for age and weight. J Lab Clin Med. 132:1998;383-389.
3. Bjarnason N.H., Sarkar S., Duong T., Mitlak B., Delmas P.D., Christiansen C. Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis. Osteoporos Int. 12:2001;922-930.
4. Black D.M., Arden N.K., Palermo L., Pearson J., Cummings S.R. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res. 14:1999;821-828.
5. Blake G.M., Park-Holohan S.J., Fogelman I. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate. J Nucl Med. 43:2002;338-345.
6. Boivin G., Chavassieux P., Yates A.J., Meunier P.J. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 27:2000;687-694.
7. Carnevale V., Dicembrino F., Frusciante V., Chiodini I., Minisola S., Scillitani A. Different patterns of global and regional skeletal uptake of 99mTc-methylene diphosphonate with age relevance to the pathogenesis of bone loss . J Nucl Med. 41:2000;1478-1483.
8. Prophylaxis and treatment of osteoporosis. Am J Med. 90:1991;107-110.
9. Cosman F., Morgan D.C., Nieves J.W., Shen V., Luckey M.M., Dempster D.W., Lindsay R., Parisien M. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res. 12:1997;958-966.
10. Cummings S.R., Karpf D.B., Harris F., Genant H.K., Ensrud K., LaCroix A.Z., Black D.M. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 112:2002;281-289.
11. Eastell R., Barton I., Hannon R.A., Chines A., Garnero P., Delmas P.D. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res. 18:(6):2003;1051-1056.
12. Eaton B., Nelson D.A. Calcium in evolutionary perspective. Am J Clin Nutr. 54:1991;281S-287S.
13. Erem C., Tanakol R., Alagol F., Omer B., Cetin O. Relationship of bone turnover parameters, endogenous hormones and vitamin D deficiency to hip fracture in elderly postmenopausal women. Int J Clin Pract. 56:2002;333-337.
14. Garnero P., Hausherr E., Chapuy M.C., Marcelli C., Grandjean H., Muller C., Cormier C., Bréart G., Meunier P.J., Delmas P.D. Markers of bone resorption predict hip fracture in elderly women The EPIDOS Prospective Study . J Bone Miner Res. 11:1996;1531-1538.
15. Garnero P., Sornay-Rendu E., Duboeuf F., Delmas P.D. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years the OFELY study . J Bone Miner Res. 14:1999;1614-1621.
16. Garnero P. Markers of bone turnover for the prediction of fracture risk. Osteoporos Int. 11:(Suppl 6):2000;S55-S65.
17. Hassager C., Jensen S.B., Gotfredsen A., Christiansen C. The impact of measurement errors on the diagnostic value of bone mass measurements theoretical considerations . Osteoporos Int. 1:1991;250-256.
18. Heaney R.P. Sodium, potassium, phosphorus, magnesium. Holick M., Dawson-Hughes B. Nutrition and Bone Health. 2003;Humana Press, Totowa, NJ. in press.
19. Heaney R.P., Yates A.J., Santora A.C. II. Bisphosphonate effects and the bone remodeling transient. J Bone Miner Res. 12:1997;1143-1151.
20. Hochberg M.C., Greenspan S., Wasnich R.D., Miller P., Thompson D.E., Ross P.D. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab. 87:2002;1586-1592.
21. Hui S.L., Slemenda C.W., Johnston C.C. Jr. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 81:1988;1804-1809.
22. Johnell O., Oden A., De Laet C., Garnero P., Delmas P.D., Kanis J.A. Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int. 13:2002;523-526.
23. Johnell O., Scheele W.H., Lu Y., Reginster J.-Y., Need A.G., Seeman E. Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 87:2002;985-992.
24. Kanis J.A., Melton L.J. III, Christiansen C., Johnston C.C. Jr, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 9:1994;1137-1141.
25. Khosla S., Melton L.J. III, Wermers R.A., Crowson C.S., O'Fallon W.M., Riggs B.L. Primary hyperparathyroidism and the risk of fracture a population-based study . J Bone Miner Res. 14:1999;1700-1707.
26. Kuhn T. The Structure of Scientific Revolutions. 1962;University of Chicago Press, Chicago, IL.
27. Langdahl B.L., Mortensen L., Vesterby A., Eriksen E.F., Charles P. Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone. 18:1996;103-108.
28. Looker A.C., Johnston C.C. Jr, Wahner H.W., Dunn W.L., Calvo M.S., Harris T.B., Heyse S.P., Lindsay R. Prevalence of low femoral bone density in older US women from NHANES-III. J Bone Miner Res. 10:1995;796-802.
29. McClung M.R. Therapy for fracture prevention. JAMA. 282:1999;687-689.
30. McKane W.R., Khosla S., Egan K.S., Robins S.P., Burritt M.F., Riggs B.L. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab. 81:1996;1699-1703.
31. Meier D.E., Luckey M.M., Wallenstein S., Clemens T.L., Orwoll E.S., Waslien C.I. Calcium, vitamin D, and parathyroid hormone status in young white and black women association with racial differences in bone mass . J Clin Endocrinol Metab. 72:1991;703-710.
32. Melton L.J. III, Chrischilles E.A., Cooper C., Lane A.W., Riggs B.L. How many women have osteoporosis? J Bone Miner Res. 7:1992;1005-1010.
33. Melton L.J. III, Khosla S., Atkinson E.J., O'Fallon W.M., Riggs B.L. Relationship of bone turnover to bone density and fractures. J Bone Miner Res. 12:1997;1083-1091.
34. Calcif Tissue Int. 53:(Suppl 1):1993;S1-S176.
35. New S.A. The role of the skeleton in acid-base homeostasis. Proceedings Nutr Society. 61:2002;151-164.
36. Oxlund H., Mosekilde L.i, Ortoft G. Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone. 19:1996;479-484.
37. Parfitt A.M. High bone turnover is intrinsically harmful two paths to a similar conclusion . J Bone Miner Res. 17:2002;1558-1559.
38. Recker RR, Lappe JM, Davies KM, Heaney RP. Transmenopausal changes in bone remodeling: serial bone biopsies. J Bone Miner Res (submitted) 2003.
39. Riggs B.L., Melton L.J. III, O'Fallon W.M. Drug therapy for vertebral fractures in osteoporosis evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy . Bone. 18:1996;197S-210S.
40. Riggs B.L., Melton L.J. III. Bone turnover matters the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density . J Bone Miner Res. 17:2002;11-14.
41. Ross P.D., Davis J.W., Epstein R.S., Wasnich R.D. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 114:1991;919-923.
42. Ross P.D., Kress B.C., Parson R.E., Wasnich R.D., Armour K.A., Mizrahi I.A. Serum bone alkaline phosphatase and calcaneus bone density predict fractures a prospective study . Osteoporos Int. 11:2000;76-82.
43. Sarkar S., Mitlak B.H., Wong M., Stock J.L., Black D.M., Harper K.D. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res. 17:2002;1-10.
44. Wastney M.E., Martin B.R., Peacock M., Smith D., Jiang X.Y., Jackman L.A., Weaver C.M. Changes in calcium kinetics in adolescent girls induced by high calcium intake. J Clin Endocrinol Metab. 85:2000;4470-4475.